U.S. Markets open in 4 hrs 43 mins
S&P Futures
2,464.00
-3.50 (-0.14%)Dow Futures
21,988.00
-23.00 (-0.10%)
| Previous Close | 46.61 |
| Open | 46.44 |
| Bid | 46.75 x 600 |
| Ask | 46.78 x 1000 |
| Day's Range | 46.31 - 46.58 |
| 52 Week Range | 38.05 - 50.22 |
| Volume | 413,268 |
| Avg. Volume | 145,685 |
| Market Cap | 28.68B |
| Beta | 0.85 |
| PE Ratio (TTM) | 19.85 |
| EPS (TTM) | 2.34 |
| Earnings Date | N/A |
| Dividend & Yield | 0.51 (1.12%) |
| Ex-Dividend Date | 2017-05-11 |
| 1y Target Est | 51.00 |
- ACCESSWIRE•8 days ago
Corporate News Blog - Fresenius Medical Care to Acquire NxStage Medical to Strengthen Its Vertically Integrated Dialysis Business
LONDON, UK / ACCESSWIRE / August 9, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Fresenius Medical Care AG & Co. KGAA (NYSE: FMS ), following which ...
- The Wall Street Journal•9 days ago
[$$] Fresenius Unit Buys NxStage Medical in $2 Billion Dialysis Deal
Fresenius’s minority-owned kidney dialysis business agreed to acquire NxStage Medical Inc. for about $2 billion.
- Motley Fool•9 days ago
Buyout Bid Overshadows NxStage Medical's Losses
The pending acquisition by Fresenius put NxStage's second-quarter financial report in a much different context.
